Social CareHTSHNCT06677645
Evaluation of Medical and Social Care for Elderly Patients, Between Hospital and Home: TEMPORARY ACCOMMODATION Out of Hospitalization by Nursing Home and Long-Term Care Units in Ile-de-France Region
An observational study of Social Care and Medical Care, run by Gérond'if at 10 sites in France.
Trial summary
Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Social Care, Medical Care, Elderly Patients
- How many people
- 258 participants
- Where
- 10 sitesFrance
- Study dates
- 20 Nov 2024to 20 Nov 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 258 subjects in the prospective group. Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study.
Who may be able to join
- Patient selection criteria
- Patient male or female at least 60 years of age, as initially defined with the Regional Health Agency, discharged from hospital,
- Oral expression of non opposition to participation in the study, documented in the medical record by the physician,
- Presenting a defined and feasible plan for returning home,
- Whose social/medical situation (stabilized) does not allow an immediate return home after hospitalization.
- Caregiver selection criteria
Show all 15Show fewer
- Person with an unpaid caregiving activity for their relative in HTSH,
- Person verbally expressing their non-opposition to participating in the study, and documented in the medical record of the patient they are helping,
- A person who is able to understand the study questionnaires and evaluations, and is able to answer them without the help of a third party.
- Professional selection criteria
- Salaried professional, nursing or not, regularly and directly involved in the HTSH circuit, whether in hospital or in nursing home / long term care units, for at least 6 months,
- Oral expression of non opposition to participation in the study, documented by the establishment.
- Non-inclusion Criteria:
- Be already included in another clinical study,
- Benefit from a legal protection measure or be unable to express their consent, in accordance with article L1121-8 of the French Public Health Code.
Who cannot join
None listed.
Trial locations and contacts
10 sites in 1 country. Contact the study team or a site near you to ask about taking part.
10 sites in 1 country
France10 sites, 9 recruiting
- Not yet recruiting
Résidence ZEMGOR
Cormeilles-en-Parisis, 95240
François CHARY, Dr, 33 (0)1 34 50 43 50, docteurfgc@outlook.com
- Recruiting
EHPAD Pierre TABANOU
L'Haÿ-les-Roses, 94240
Richard CABROLIER, Dr, 33(0)7 86 05 23 53, docteur.cabrolier@wanadoo.fr
- Not yet recruiting
Groupe Hospitalier Sud Ile de France (GHSIF)
Melun, 77000
Cyrus MOINI, Dr, 33(0)1 81 74 20 36, cyrus.moini@ghsif.fr
- Not yet recruiting
GHU Lariboisière
Paris, 75010
Marie JAGER, Dr, +33 0619229316, marie.jager@aphp.fr
- Recruiting
Broca Hospital
Paris, 75013
Olivier HANON, Professor, 33 (0) 1 44 08 33 81, olivier.hanon@aphp.fr
- Recruiting
USDL Vaugirard, APHP
Paris, 75015
Galdric ORVOEN, Dr, 33 (0)1 44 08 36 44, galdric.orvoen@aphp.fr
- Recruiting
CHU Bicêtre
Paris, Île-de-France Region, 94270
Pauline RABIER-LEBRUN, Dr, 33(0) 1 45 21 70 22, pauline.rabier@aphp.fr
- Not yet recruiting
Centre Hospitalier de Rambouillet
Rambouillet, 78514
Bruno THUBERT, Dr, +33 0670117178, B.Thubert@ch-rambouillet.fr
- Active, not recruiting
Centre Hospitalier de Versailles
Versailles, 78157
- Not yet recruiting
Hopital Paul Brousse
Villejuif, 94800
Johane CEDILE, Dr, +33 0652058294, johane.cedile@aphp.fr
About this study
Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services.
Read the detailed description
This is a multi-center study involving many hospital departments temporary accommodation at the end of hospitalization in several Nursing home/long term care units in Ile de France region. The temporary accommodation program was designed for elderly people living at home to find an accommodation solution in nursing home to meet a short-term need. Temporary accommodation beds are deployed and perpetuated in the Île-de-France region by the Regional Health Agency, physically grouped together in establishments within units with dedicated staff. The resources allocated to these beds have been increased. The aim of the study is to demonstrate the efficiency of the HTSH circuit, for elderly patients leaving hospital, in their medical and social care and the decision or not to return home. This project is supported by Regional Health Agency (ARS-IDF).
- Conditions
- Social Care, Medical Care, Elderly Patients
- Keywords
- social care, Tempory hospitalization, Elderly people, Medical care, medical-economic study
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Prospective group | 258 subjects in the prospective group | |
| Retrospective group | Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Study to investigate the impact of HTSH on length of hospital stay in referring services
The main assessment criterion is based on the average length of stay observed at the end of the study, compared with that of the previous two years, 2021 and 2022, in the referring services.
Measured: 24 months
Secondary outcomes (4)
Analysis of pathways and plans for returning home
Evaluation criteria:
Calculation of the proportion of patients in the life project on admission to nursing home / long term care units and the return home at the end of the stay.
Measured: 24 months
Analysis of HTSH patient profiles a) Proportion of eligible patients and their comorbidities b) Social profile + main reason for hospitalization of patients admitted to HTSH
Evaluation criteria:
Ratio of hospital ward activity data to pre-screening data collected during the study.
Measured: 24 months
Analysis of discharges and patient outcomes
Proportion of patients remaining at home in the medium term Patients' functional outcome after the trial
Measured: 24 months
Quality of life and caregiver benefit analysis
Quality of life assessment
Measured: 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Nov 2024
- Study start20 Nov 2024
- Primary completion20 Nov 2026 (estimated)
- Study completion20 Nov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Social CareStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 258 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Gérond'if
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06677645
- Sponsor's protocol ID
- 2024-A00023-44
- Acronym
- HTSH
- Status last verified
- Jun 2025
- First submitted
- 23 Oct 2024
- Last updated
- 13 Jun 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 13 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Medical and Social Care for Elderly Patients, Between Hospital and Home: TEMPORARY ACCOMMODATION Out of Hospitalization by Nursing Home and Long-Term Care Units in Ile-de-France Region
- ClinicalTrials.gov ID
- NCT06677645
- Acronym / sponsor ID
- HTSH / 2024-A00023-44
- Conditions
- Social Care, Medical Care, Elderly Patients
- Keywords
- social care, Tempory hospitalization, Elderly people, Medical care, medical-economic study
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 258 participants (estimated)
- Lead sponsor
- Gérond'ifUniversity, hospital or other
- Study start
- 20 Nov 2024 (actual)
- Primary completion
- 20 Nov 2026 (estimated)
- Study completion
- 20 Nov 2027 (estimated)
- First posted
- 7 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services.
Detailed description
This is a multi-center study involving many hospital departments temporary accommodation at the end of hospitalization in several Nursing home/long term care units in Ile de France region. The temporary accommodation program was designed for elderly people living at home to find an accommodation solution in nursing home to meet a short-term need. Temporary accommodation beds are deployed and perpetuated in the Île-de-France region by the Regional Health Agency, physically grouped together in establishments within units with dedicated staff. The resources allocated to these beds have been increased. The aim of the study is to demonstrate the efficiency of the HTSH circuit, for elderly patients leaving hospital, in their medical and social care and the decision or not to return home. This project is supported by Regional Health Agency (ARS-IDF).
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Prospective group | – | –258 subjects in the prospective group |
| Retrospective group | – | –Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study. |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 258 subjects in the prospective group. Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study.
Key inclusion criteria (15 listed)
- Non-inclusion Criteria:
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Study to investigate the impact of HTSH on length of hospital stay in referring services
Time frame: 24 months
The main assessment criterion is based on the average length of stay observed at the end of the study, compared with that of the previous two years, 2021 and 2022, in the referring services.
4 secondary outcomes
Analysis of pathways and plans for returning home
Time frame: 24 months
Analysis of HTSH patient profiles a) Proportion of eligible patients and their comorbidities b) Social profile + main reason for hospitalization of patients admitted to HTSH
Time frame: 24 months
Analysis of discharges and patient outcomes
Time frame: 24 months
Quality of life and caregiver benefit analysis
Time frame: 24 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jun 2025.
- Individual participant dataSharing planned: Yes
Related trials for Social Care
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Not yet recruiting
Impact of Pharmacotherapy Optimization in Polymedicated Lebanese Older Adults in Primary Health Care Centers
Older Adults (65 Years and Older), Polypharmacy (People Under Treatment With 5 or More Drugs)
Active, not recruiting
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
Dementia Caregivers, Diabetes
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Active, not recruiting
Economic Empowerment and Health Promotion of Uganda Grandmother-caregivers.
Financial Burden, Health Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
10 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Social Care and Medical Care, run by Gérond'if at 10 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 15 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 10 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact ISABELLE DUFOUR (33 (0) 185781011, isabelle.dufour@gerondif.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Study to investigate the impact of HTSH on length of hospital stay in referring services (time frame: 24 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2025.